Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolaus Andratschke

Showing results (1-10 of 233) with videos related to

Pageof 24
Sort By:
The Lancet. Oncology|June 26, 2012
Stereotactic ablative radiotherapy for inoperable stage I NSCLCNicolaus Andratschke
International Journal of Radiation Oncology, Biology, Physics|March 6, 2007
Salvage radiotherapy in patients with PET-Positive residual non-Hodgkin's lymphoma after chemotherapy: in regard to Kahn et al. (Int J Radiat Oncol Biol Phys 2006;66:961-965)Carsten Nieder, Nicolaus Andratschke
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 11, 2020
[Role of hippocampal avoidance during therapeutic whole-brain radiotherapy]Michael Mayinger, Nicolaus Andratschke
Medical Hypotheses|January 28, 2012
Adding cetuximab to stereotactic radiotherapy for non-small cell lung cancer might reduce local failure ratesCarsten Nieder, Nicolaus Andratschke
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 10, 2026
Erratum to "Response to "Regarding Dähler K et al." Evaluation of the prognostic value of the ESTRO/EORTC classification of reirradiation in patients with non-small cell lung cancer" [Radiother. Oncol. 213 (2025) 111214]Jonas Willmann, Nicolaus Andratschke
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 14, 2015
[Randomised comparison of stereotactic body radiotherapy versus lobectomy in stage I NSCLC--level I evidence at last?]Matthias Guckenberger, Nicolaus Andratschke
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 21, 2025
Response to "Regarding Dähler K et al. '' Evaluation of the prognostic value of the ESTRO/EORTC classification of reirradiation in patients with non-small cell lung cancer"Jonas Willmanna, Nicolaus Andratschke
Translational Lung Cancer Research|March 26, 2015
SBRT in operable early stage lung cancer patientsJohannes Roesch, Nicolaus Andratschke, Matthias Guckenberger
Radiation Oncology (London, England)|July 3, 2007
Experimental concepts for toxicity prevention and tissue restoration after central nervous system irradiationCarsten Nieder, Nicolaus Andratschke, Sabrina T Astner
International Journal of Radiation Oncology, Biology, Physics|November 25, 2019
In Regard to Ohri et alRainer J Klement, Nicolaus Andratschke, Matthias Guckenberger
Pageof 24

Showing results (1-10 of 233) with videos related to

Sort By:
Pageof 24
The Lancet. Oncology|June 26, 2012
Stereotactic ablative radiotherapy for inoperable stage I NSCLCNicolaus Andratschke
International Journal of Radiation Oncology, Biology, Physics|March 6, 2007
Salvage radiotherapy in patients with PET-Positive residual non-Hodgkin's lymphoma after chemotherapy: in regard to Kahn et al. (Int J Radiat Oncol Biol Phys 2006;66:961-965)Carsten Nieder, Nicolaus Andratschke
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 11, 2020
[Role of hippocampal avoidance during therapeutic whole-brain radiotherapy]Michael Mayinger, Nicolaus Andratschke
Medical Hypotheses|January 28, 2012
Adding cetuximab to stereotactic radiotherapy for non-small cell lung cancer might reduce local failure ratesCarsten Nieder, Nicolaus Andratschke
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 10, 2026
Erratum to "Response to "Regarding Dähler K et al." Evaluation of the prognostic value of the ESTRO/EORTC classification of reirradiation in patients with non-small cell lung cancer" [Radiother. Oncol. 213 (2025) 111214]Jonas Willmann, Nicolaus Andratschke
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 14, 2015
[Randomised comparison of stereotactic body radiotherapy versus lobectomy in stage I NSCLC--level I evidence at last?]Matthias Guckenberger, Nicolaus Andratschke
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 21, 2025
Response to "Regarding Dähler K et al. '' Evaluation of the prognostic value of the ESTRO/EORTC classification of reirradiation in patients with non-small cell lung cancer"Jonas Willmanna, Nicolaus Andratschke
Translational Lung Cancer Research|March 26, 2015
SBRT in operable early stage lung cancer patientsJohannes Roesch, Nicolaus Andratschke, Matthias Guckenberger
Radiation Oncology (London, England)|July 3, 2007
Experimental concepts for toxicity prevention and tissue restoration after central nervous system irradiationCarsten Nieder, Nicolaus Andratschke, Sabrina T Astner
International Journal of Radiation Oncology, Biology, Physics|November 25, 2019
In Regard to Ohri et alRainer J Klement, Nicolaus Andratschke, Matthias Guckenberger
Pageof 24